Burrage Capital Management as of June 30, 2020
Portfolio Holdings for Burrage Capital Management
Burrage Capital Management holds 26 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Epizyme | 10.0 | $14M | 891k | 16.06 | |
| Mei Pharma | 8.7 | $12M | 3.0M | 4.13 | |
| Ptc Therapeutics I (PTCT) | 6.4 | $9.1M | 179k | 50.74 | |
| G1 Therapeutics (GTHX) | 6.3 | $9.1M | 374k | 24.26 | |
| Iveric Bio | 5.3 | $7.5M | 1.5M | 5.10 | |
| Orthopediatrics Corp. (KIDS) | 5.2 | $7.4M | 170k | 43.76 | |
| Anaptysbio Inc Common (ANAB) | 5.1 | $7.3M | 328k | 22.34 | |
| ADC Therapeutics SA (ADCT) | 4.4 | $6.3M | 135k | 46.81 | |
| Cytokinetics (CYTK) | 4.3 | $6.2M | 262k | 23.57 | |
| NeoGenomics (NEO) | 4.1 | $5.9M | 190k | 30.98 | |
| Aimmune Therapeutics | 3.9 | $5.6M | 333k | 16.71 | |
| Fulcrum Therapeutics (FULC) | 3.7 | $5.3M | 292k | 18.29 | |
| Y Mabs Therapeutics (YMAB) | 3.7 | $5.3M | 123k | 43.20 | |
| Turning Point Therapeutics I | 3.5 | $5.0M | 77k | 64.60 | |
| Frequency Therapeutics | 3.3 | $4.7M | 204k | 23.25 | |
| Insmed (INSM) | 3.2 | $4.6M | 165k | 27.54 | |
| Regenxbio Inc equity us cm (RGNX) | 3.0 | $4.2M | 115k | 36.83 | |
| Aurinia Pharmaceuticals (AUPH) | 2.9 | $4.2M | 256k | 16.25 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.9 | $4.1M | 236k | 17.52 | |
| Avrobio Ord (AVRO) | 2.8 | $3.9M | 226k | 17.45 | |
| Adverum Biotechnologies | 2.3 | $3.3M | 156k | 20.88 | |
| Apellis Pharmaceuticals (APLS) | 1.7 | $2.4M | 75k | 32.67 | |
| Merus N V (MRUS) | 1.6 | $2.3M | 140k | 16.09 | |
| Zogenix | 1.3 | $1.9M | 70k | 27.01 | |
| Aduro Biotech | 0.2 | $314k | 136k | 2.31 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $241k | 15k | 16.06 |
